Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards
Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, has been recognized by Strategic Healthcare Programs (SHP) for outstanding patient and caregiver satisfaction in 2023. 92 Amedisys care centers received SHPBest™ Patient Satisfaction Awards, with 14 centers earning Premier Performer status (top 5%) and 78 centers achieving Superior Performer status (top 20%). Notably, 13 care centers have maintained award-winning performance for five consecutive years.
The SHPBest™ award program evaluates over 3,200 home health providers and 1,750 hospice providers based on HHCAHPS and CAHPS Hospice survey satisfaction scores. This recognition highlights Amedisys' commitment to delivering exceptional care and maintaining high patient and caregiver satisfaction levels across its network.
Amedisys, Inc. (NASDAQ: AMED), un fornitore leader di assistenza sanitaria domiciliare, hospice e cure ad alta intensità, è stata riconosciuta da Strategic Healthcare Programs (SHP) per l'eccezionale soddisfazione dei pazienti e dei caregiver nel 2023. 92 centri di cura Amedisys hanno ricevuto i premi SHPBest™ per la soddisfazione dei pazienti, con 14 centri che hanno ottenuto lo status di Premier Performer (top 5%) e 78 centri che hanno raggiunto lo status di Superior Performer (top 20%). È notevole che 13 centri di cura abbiano mantenuto performance premiate per cinque anni consecutivi.
Il programma di premi SHPBest™ valuta oltre 3.200 fornitori di assistenza sanitaria domiciliare e 1.750 fornitori di hospice basandosi sui punteggi di soddisfazione delle indagini HHCAHPS e CAHPS Hospice. Questo riconoscimento sottolinea l'impegno di Amedisys nel fornire cure eccezionali e nel mantenere alti livelli di soddisfazione dei pazienti e dei caregiver in tutta la sua rete.
Amedisys, Inc. (NASDAQ: AMED), un proveedor líder de atención médica a domicilio, hospice y cuidados de alta complejidad, ha sido reconocida por Strategic Healthcare Programs (SHP) por su sobresaliente satisfacción de pacientes y cuidadores en 2023. 92 centros de atención de Amedisys recibieron los premios SHPBest™ por la satisfacción del paciente, con 14 centros obteniendo el estatus de Premier Performer (top 5%) y 78 centros logrando el estatus de Superior Performer (top 20%). Destaca que 13 centros de atención han mantenido un rendimiento premiado durante cinco años consecutivos.
El programa de premios SHPBest™ evalúa a más de 3,200 proveedores de atención médica a domicilio y 1,750 proveedores de hospice basándose en los puntajes de satisfacción de las encuestas HHCAHPS y CAHPS Hospice. Este reconocimiento destaca el compromiso de Amedisys de ofrecer atención excepcional y mantener altos niveles de satisfacción de pacientes y cuidadores en toda su red.
Amedisys, Inc. (NASDAQ: AMED), 가정 건강 관리, 호스피스 및 고위험 치료의 선도적인 제공업체로, 2023년에 환자 및 보호자 만족도에서 뛰어난 성과를 인정받았습니다. 92 개의 Amedisys 케어 센터가 SHPBest™ 환자 만족도 상을 받았으며, 14 개 센터가 Premier Performer 상태를 획득 (상위 5%) 하였고 78 개 센터가 Superior Performer 상태에 도달 (상위 20%) 하였습니다. 특히, 13 개의 케어 센터가 5년 연속으로 수상 경력을 유지하고 있습니다.
SHPBest™ 상 프로그램은 3,200개 이상의 가정 건강 제공업체와 1,750개 호스피스 제공업체를 HHCAHPS 및 CAHPS 호스피스 설문조사 만족도 점수에 따라 평가합니다. 이 인정은 Amedisys가 뛰어난 치료를 제공하고 네트워크 전반에 걸쳐 높은 환자 및 보호자 만족도를 유지하기 위한 노력을 강조합니다.
Amedisys, Inc. (NASDAQ: AMED), un fournisseur de premier plan en soins de santé à domicile, soins palliatifs et soins de haute intensité, a été reconnu par Strategic Healthcare Programs (SHP) pour sa satisfaction exceptionnelle des patients et des aidants en 2023. 92 centres de soins Amedisys ont reçu les prix SHPBest™ pour la satisfaction des patients, avec 14 centres atteignant le statut de Premier Performer (top 5%) et 78 centres obtenant le statut de Superior Performer (top 20%). Il est à noter que 13 centres de soins ont maintenu une performance primée pendant cinq années consécutives.
Le programme de prix SHPBest™ évalue plus de 3 200 fournisseurs de soins de santé à domicile et 1 750 fournisseurs de soins palliatifs sur la base des scores de satisfaction des enquêtes HHCAHPS et CAHPS Hospice. Cette reconnaissance souligne l'engagement d'Amedisys à fournir des soins exceptionnels et à maintenir des niveaux de satisfaction élevés parmi les patients et les aidants au sein de son réseau.
Amedisys, Inc. (NASDAQ: AMED), ein führender Anbieter von häuslicher Gesundheitsversorgung, Hospiz- und Intensivpflege, wurde 2023 von Strategic Healthcare Programs (SHP) für herausragende Patient:innen- und Pflegekraftzufriedenheit anerkannt. 92 Amedisys Pflegezentren erhielten die SHPBest™ Auszeichnungen für Patientenzufriedenheit, wobei 14 Zentren den Status eines Premier Performers (Top 5%) und 78 Zentren den Status eines Superior Performers (Top 20%) erreichten. Bemerkenswert ist, dass 13 Pflegezentren seit fünf aufeinanderfolgenden Jahren eine preisgekrönte Leistung aufrechterhalten haben.
Das SHPBest™ Auszeichnungsprogramm bewertet über 3.200 Anbieter häuslicher Gesundheitsversorgung und 1.750 Hospizanbieter basierend auf den Zufriedenheitswerten der HHCAHPS- und CAHPS-Hospizumfragen. Diese Anerkennung hebt das Engagement von Amedisys hervor, außergewöhnliche Pflege zu leisten und hohe Zufriedenheitsniveaus für Patient:innen und Pflegekräfte in ihrem Netzwerk aufrechtzuerhalten.
- 92 Amedisys care centers recognized for high patient satisfaction scores
- 14 care centers ranked in the top 5% as Premier Performers
- 78 care centers ranked in the top 20% as Superior Performers
- 13 care centers maintained award-winning performance for 5 consecutive years
- None.
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care centers recognized by Strategic Healthcare Programs (SHP) for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients in 2023. This includes 14 care centers awarded Premier Performer, ranking in the top
“Nothing we do is possible without our incredible caregivers delivering outstanding care in the home each and every day,” stated Scott Ginn, Chief Operating Officer and Chief Financial Officer, Amedisys. “Thanks to our dedicated family of caregivers, Amedisys is truly achieving clinical distinction.”
The annual SHPBest™ award program was created to acknowledge home health and hospice agencies that consistently provide high quality service to their patients and caregivers of patients receiving hospice care. For home health, the 2023 award recipients were determined by reviewing and ranking the overall satisfaction score for more than 3,200 home health providers. For hospice, the 2023 award recipients were determined by reviewing and ranking the overall CAHPS Hospice survey satisfaction score for more than 1,750 hospice providers.
With the largest HHCAHPS and CAHPS benchmarks in the nation, SHP is in a unique position to identify and recognize organizations that have made patient, family and caregiver satisfaction a priority and have been rewarded for their efforts with high marks on the HHCAHPS and CAHPS Hospice survey.
“SHP is proud to partner with so many organizations that put a high value on providing quality patient care and we are honored to recognize the hard work and dedication of our top-performing customers with the annual SHPBest awards. These organizations deserve to be celebrated for their commitment to achieving new levels of excellence each and every year,” said Kevin Vogel, President of SHP.
Read more about the SHPBest awards program, including methodology and award recipient lists at https://www.shpdata.com/home-health/shpbest-hhcahps and https://www.shpdata.com/hospice/shpbest-cahps-hospice/.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually. For more information about the Company, please visit: www.amedisys.com.
About Strategic Healthcare Programs (SHP)
Strategic Healthcare Programs (SHP) is a leader in data analytics and benchmarking that drive daily clinical and operational decisions. Our solutions bring real-time data to post-acute providers, hospitals, and ACOs to better coordinate quality care and improve patient outcomes. Since 1996, SHP has helped more than 7,000 organizations nationwide raise the bar for healthcare performance.
| Contact: | ||
| Nick Muscato | Kendra Kimmons | |
| Amedisys, Inc. | Amedisys, Inc. | |
| Chief Strategy Officer | Media Relations | |
| 615.928.5452 | 225.299.3720 | |
| nick.muscato@amedisys.com | Kendra.kimmons@amedisys.com | |
FAQ
How many Amedisys care centers received SHPBest™ Patient Satisfaction Awards in 2023?
What percentage of Amedisys care centers were recognized as Premier Performers by SHP in 2023?
How many Amedisys care centers have maintained award-winning performance for five consecutive years?
What is the significance of the SHPBest™ award for Amedisys (AMED) in the home health and hospice industry?
